Analysts expect Arrowhead Pharmaceuticals, Inc. to report revenue of 57.49 M for Q4 26, against a range of 51.88 M to 63.09 M. The most recent reported quarter, Q3 26, came in at 75.25 M, a 66.6% beat against the 45.18 M consensus.
| Metric | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.00 | 2.50 M | 542.71 M | 27.77 M | 256.47 M | 264.03 M | 73.74 M | 75.25 M | - | - | - | - | - | - | - | - | |||||||||
| High Estimate | 60.00 M | 74.02 M | 128.11 M | 48.46 M | 176.87 M | 216.27 M | 81.97 M | 48.65 M | 63.09 M | 47.64 M | 60.48 M | 42.70 M | 86.90 M | 209.79 M | 193.42 M | 130.16 M | |||||||||
| Low Estimate | 52.85 M | 67.55 M | 113.81 M | 40.93 M | 151.23 M | 187.50 M | 72.12 M | 41.70 M | 51.88 M | 40.16 M | 50.30 M | 36.93 M | 80.51 M | 177.50 M | 168.35 M | 119.89 M | |||||||||
| Consensus Estimate | 56.43 M | 70.78 M | 120.96 M | 44.69 M | 164.05 M | 201.88 M | 77.05 M | 45.18 M | 57.49 M | 43.90 M | 55.39 M | 39.82 M | 83.71 M | 193.64 M | 180.88 M | 125.03 M |
Analysts expect Arrowhead Pharmaceuticals, Inc. to report earnings per share of -1.59 for Q4 26, against a range of -1.72 to -1.46. The most recent reported quarter, Q3 26, came in at -1.36, a 10.6% miss against the -1.23 consensus.
| Metric | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -1.36 | -1.39 | 2.75 | -1.26 | -0.11 | 0.22 | -0.93 | -1.36 | - | - | - | - | - | - | - | - | |||||||||
| High Estimate | -1.07 | -0.44 | -0.18 | -0.92 | -0.10 | 0.04 | -1.00 | -1.14 | -1.46 | -1.31 | -1.12 | -1.39 | -1.34 | -0.55 | -0.45 | -1.17 | |||||||||
| Low Estimate | -1.25 | -0.54 | -0.20 | -1.10 | -0.12 | 0.04 | -1.14 | -1.32 | -1.72 | -1.57 | -1.34 | -1.67 | -1.42 | -0.61 | -0.53 | -1.35 | |||||||||
| Consensus Estimate | -1.16 | -0.49 | -0.19 | -1.01 | -0.11 | 0.04 | -1.07 | -1.23 | -1.59 | -1.44 | -1.23 | -1.53 | -1.38 | -0.58 | -0.49 | -1.26 |
Pull Wall Street consensus for Arrowhead Pharmaceuticals, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=ARWR&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "ARWR", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=ARWR&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();